Biogen, Inc. (BIIB)
191.38
+2.39
(+1.26%)
USD |
NASDAQ |
Feb 11, 11:32
Biogen Profit Margin (Quarterly) : -2.24% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 34.40% |
| Merck & Co., Inc. | 18.06% |
| AbbVie, Inc. | 10.92% |
| Stoke Therapeutics, Inc. | -360.7% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.36% |
| Return on Assets | 4.52% |
| Return on Invested Capital | 5.34% |
| Gross Profit Margin (Quarterly) | 68.10% |
| Operating Margin (Quarterly) | 16.56% |
| Return on Net Operating Assets | 5.45% |